Evidence map›Paper›PMID 34086728›Full record

ArticlePloS one2021

Rationale and validation of a novel mobile application probing motor inhibition: Proof of concept of CALM-IT.

Elise M Cardinale, Reut Naim, Simone P Haller, Ramaris German, Christian Botz-Zapp, Jessica Bezek, David C Jangraw, Melissa A Brotman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Elise M CardinaleEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.ORCID 0000-0002-5117-6124
Reut NaimEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.
Simone P HallerEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.
Ramaris GermanEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.
Christian Botz-ZappEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.
Jessica BezekEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.
David C JangrawDepartment of Electrical and Biomedical Engineering, University of Vermont, Burlington, VT, United States of America.ORCID 0000-0002-2470-7647
Melissa A BrotmanEmotion & Development Branch, National Institute of Mental Health, Bethesda, MD, United States of America.
National Institute of Mental Health · USUniversity of Vermont · US

Funding

Unit on Neuroscience and Novel TherapeuticsZIAMH002969 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI BROTMAN, MELISSA · 2019 to 2025
$13.8M
6 · The paper itself

Abstract

Identification of behavioral mechanisms underlying psychopathology is essential for the development of novel targeted therapeutics. However, this work relies on rigorous, time-intensive, clinic-based laboratory research, making it difficult to translate research paradigms into tools that can be used by clinicians in the community. The broad adoption of smartphone technology provides a promising opportunity to bridge the gap between the mechanisms identified in the laboratory and the clinical interventions targeting them in the community. The goal of the current study is to develop a developmentally appropriate, engaging, novel mobile application called CALM-IT that probes a narrow biologically informed process, inhibitory control. We aim to leverage the rigorous and robust methods traditionally used in laboratory settings to validate this novel mechanism-driven but easily disseminatable tool that can be used by clinicians to probe inhibitory control in the community. The development of CALM-IT has significant implications for the ability to screen for inhibitory control deficits in the community by both clinicians and researchers. By facilitating assessment of inhibitory control outside of the laboratory setting, researchers could have access to larger and more diverse samples. Additionally, in the clinical setting, CALM-IT represents a novel clinical screening measure that could be used to determine personalized courses of treatment based on the presence of inhibitory control deficits.

Indexed as

AdolescentChildHumansMass ScreeningMobile ApplicationsPsychopathologySmartphone

Identifiers

PMID34086728
PMCPMC8177631
OpenAlexW3165408023

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.